2026.02.09
Cryopreservation is a cornerstone of cell-based research and biomanufacturing, but the traditional reliance on Dimethyl Sulfoxide (DMSO) poses significant challenges. DMSO can induce cellular stress, differentiation, and even toxicity, potentially compromising post-thaw viability and experimental consistency. For sensitive cell types like stem cells and primary cells, these effects are a major concern. The scientific community is actively seeking safer, more reliable alternatives to protect valuable cell stocks.
Enter Kryogene® Cell Freezing Media – DMSO Free, a next-generation solution engineered to overcome these limitations. This innovative formulation completely eliminates DMSO, removing a key variable and potential source of cytotoxicity from your preservation process.
So, what sets the Kryogene® platform apart? Its advantages are built on a foundation of quality and safety. The media is manufactured under stringent cGMP conditions and utilizes only USP-grade components, ensuring the highest standards of purity and batch-to-batch consistency. It is pre-formulated for immediate use, saving precious laboratory time and eliminating formulation errors.
Further enhancing its profile for critical applications, Kryogene® media is both serum-free and entirely free of animal-derived components. This defined composition minimizes lot-to-lot variability and reduces the risk of contamination, making it ideal for clinical and therapeutic cell processing. Each batch undergoes rigorous cell-based release testing and is documented with a detailed, lot-specific Certificate of Analysis (COA), guaranteeing performance you can trust.
By switching to a DMSO-free protocol with Kryogene®, researchers gain not just a reagent, but a strategic advantage: the confidence that their cells are preserved under optimal, controlled, and gentle conditions, ready to perform upon revival.
